Cardiff Oncology logo

Cardiff Oncology Share Price Today

(NASDAQ: CRDF)

Cardiff Oncology share price is $4.27 & ₹371.36 as on 6 Mar 2025, 2.30 'hrs' IST

$4.27

0.53

(14.32%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Cardiff Oncology share price in Dollar and Rupees. Guide to invest in Cardiff Oncology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cardiff Oncology, along with analyst recommendations, forecasts, and comprehensive financials.

Cardiff Oncology share price movements

  • Today's Low: $3.75
    Today's High: $4.31

    Day's Volatility :12.89%

  • 52 Weeks Low: $2.01
    52 Weeks High: $6.42

    52 Weeks Volatility :68.69%

Cardiff Oncology (CRDF) Returns

PeriodCardiff Oncology IncSector (Health Care)Index (Russel 2000)
3 Months
82.48%
3.7%
0.0%
6 Months
93.21%
-2.8%
0.0%
1 Year
9.77%
2.5%
0.0%
3 Years
89.78%
12.9%
-11.6%

Cardiff Oncology (CRDF) Key Statistics

in dollars & INR

Previous Close
$3.735
Open
$3.76
Today's High
$4.305
Today's Low
$3.75
Market Capitalization
$248.5M
Today's Volume
$1.3M
52 Week High
$6.42
52 Week Low
$2.01
Revenue TTM
$683.0K
EBITDA
$-48.2M
Earnings Per Share (EPS)
$-0.93
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-59.51%

How to invest in Cardiff Oncology Stock (CRDF) from India?

It is very easy for Indian residents to invest directly in Cardiff Oncology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cardiff Oncology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cardiff Oncology or CRDF on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cardiff Oncology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cardiff Oncology shares which would translate to 0.204 fractional shares of Cardiff Oncology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cardiff Oncology, in just a few clicks!

Returns in Cardiff Oncology (CRDF) for Indian investors in Rupees

The Cardiff Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cardiff Oncology investment value today

Current value as on today

₹1,14,717

Returns

₹14,717

(+14.72%)

Returns from Cardiff Oncology Stock

₹9,769 (+9.77%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Cardiff Oncology (CRDF)

-55%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Cardiff Oncology Stock from India on INDmoney has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cardiff Oncology

  • COMMODORE CAPITAL LP

    8.09%

  • BlackRock Inc

    4.27%

  • Vanguard Group Inc

    3.43%

  • Orbimed Advisors, LLC

    2.31%

  • Adage Capital Partners Gp LLC

    1.94%

  • Geode Capital Management, LLC

    1.48%

Analyst Recommendation on Cardiff Oncology

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Cardiff Oncology(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Cardiff Oncology Stock (CRDF)

What analysts predicted

Upside of 213.82%

Target:

$13.40

Current:

$4.27

Insights on Cardiff Oncology Stock (Ticker Symbol: CRDF)

  • Price Movement

    In the last 7 days, CRDF stock has moved up by 5.2%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 165.0K → 151.0K (in $), with an average decrease of 8.5% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -11.85M → -11.78M (in $), with an average increase of 0.6% per quarter
  • CRDF vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 56.7%
  • Price to Sales

    ForCRDF every $1 of sales, investors are willing to pay $305.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Cardiff Oncology Technicals Summary

Sell

Neutral

Buy

Cardiff Oncology is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cardiff Oncology (CRDF) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cardiff Oncology Inc logo
0.0%
93.21%
9.77%
89.78%
255.83%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cardiff Oncology Inc logo
NA
NA
NA
-0.83
-0.6
-0.34
NA
1.25
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cardiff Oncology Inc logo
Buy
$248.5M
255.83%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Cardiff Oncology

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in triple negative breast cancer and small cell lung cancer; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Organization
Cardiff Oncology
Employees
32
CEO
Dr. Mark Erlander Ph.D.
Industry
Health Services

Management People of Cardiff Oncology

NameTitle
Dr. Mark Erlander Ph.D.
CEO & Director
Mr. James E. Levine
Chief Financial Officer
Dr. Fairooz F. Kabbinavar FACP, M.D.
Chief Medical Officer
Dr. Tod Smeal Ph.D.
Chief Scientific Officer
Ms. Elizabeth Anderson
VP of Finance & Administration
Ms. Brigitte Lindsay
Senior Vice President of Finance
Mr. Charles Monahan R.Ph.
Senior Vice President of Regulatory Affairs

Important FAQs about investing in CRDF Stock from India :

What is Cardiff Oncology share price today?

Cardiff Oncology share price today stands at $4.27, Open: $3.76 ; Previous Close: $3.74 ; High: $4.31 ; Low: $3.75 ; 52 Week High: $6.42 ; 52 Week Low: $2.01.

The stock opens at $3.76, after a previous close of $3.74. The stock reached a daily high of $4.31 and a low of $3.75, with a 52-week high of $6.42 and a 52-week low of $2.01.

Can Indians buy Cardiff Oncology shares?

Yes, Indians can invest in the Cardiff Oncology (CRDF) from India.

With INDmoney, you can buy Cardiff Oncology at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cardiff Oncology at zero transaction cost.

How can I buy Cardiff Oncology shares from India?

It is very easy to buy Cardiff Oncology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cardiff Oncology (CRDF) be purchased?

Yes, you can buy fractional shares of Cardiff Oncology with INDmoney app.

What are the documents required to start investing in Cardiff Oncology stocks?

To start investing in Cardiff Oncology, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cardiff Oncology Stock (CRDF)?

Today’s highest price of Cardiff Oncology (CRDF) is $4.31.

Today’s lowest price of Cardiff Oncology (CRDF) is $3.75.

What is today's market capitalisation of Cardiff Oncology?

Today's market capitalisation of Cardiff Oncology CRDF is 248.5M

What is the 52 Week High and Low Range of Cardiff Oncology Stock (CRDF)?

  • 52 Week High

    $6.42

  • 52 Week Low

    $2.01

What are the historical returns of Cardiff Oncology (CRDF)?

  • 1 Month Returns

    0%

  • 3 Months Returns

    93.21%

  • 1 Year Returns

    9.77%

  • 5 Years Returns

    255.83%

Who is the Chief Executive Officer (CEO) of Cardiff Oncology ?

Dr. Mark Erlander Ph.D. is the current Chief Executive Officer (CEO) of Cardiff Oncology.